Literature DB >> 15178763

Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation.

Vannakambadi K Ganesh1, Scott A Smith, Girish J Kotwal, Krishna H M Murthy.   

Abstract

Vaccinia virus complement control protein (VCP), a homolog of the regulators of the complement activation family of proteins, inhibits complement activation through mechanisms similar to human fluid-phase complement regulators factor H and C4b-binding protein. VCP has a heparin-binding activity that assists vaccinia in host interactions. Interaction with cell-surface polyanions like heparin is centrally important in the functioning of fluid-phase complement regulators and is the basis of host-target discrimination by the alternative pathway. We report the structure of VCP in complex with a heparin decasaccharide, which reveals changes in VCP that might be pertinent to complement regulation. Properties that VCP shares with fluid-phase complement regulators suggest that such conformational changes may be of relevance in the functioning of other complement regulators. Additionally, comparison of VCP-heparin interactions with potentially similar interactions in factor H might enable understanding of the structural basis of familial hemolytic uremic syndrome, attributed to mutational disruption of heparin and C3b binding by factor H.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15178763      PMCID: PMC428448          DOI: 10.1073/pnas.0400744101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  56 in total

1.  Each of the three binding sites on complement factor H interacts with a distinct site on C3b.

Authors:  T S Jokiranta; J Hellwage; V Koistinen; P F Zipfel; S Meri
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

2.  RETRACTED: Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans.

Authors:  K H Murthy; S A Smith; V K Ganesh; K W Judge; N Mullin; P N Barlow; C M Ogata; G J Kotwal
Journal:  Cell       Date:  2001-01-26       Impact factor: 41.582

Review 3.  Role of heparan sulfate in fibroblast growth factor signalling: a structural view.

Authors:  L Pellegrini
Journal:  Curr Opin Struct Biol       Date:  2001-10       Impact factor: 6.809

4.  Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.

Authors:  A Nicholls; K A Sharp; B Honig
Journal:  Proteins       Date:  1991

Review 5.  Structure and distribution of modules in extracellular proteins.

Authors:  P Bork; A K Downing; B Kieffer; I D Campbell
Journal:  Q Rev Biophys       Date:  1996-05       Impact factor: 5.318

Review 6.  Therapeutic inhibition of the complement system.

Authors:  S C Makrides
Journal:  Pharmacol Rev       Date:  1998-03       Impact factor: 25.468

7.  Crystal structure of two CD46 domains reveals an extended measles virus-binding surface.

Authors:  J M Casasnovas; M Larvie; T Stehle
Journal:  EMBO J       Date:  1999-06-01       Impact factor: 11.598

Review 8.  Complement factor H and hemolytic uremic syndrome.

Authors:  P F Zipfel; C Skerka; J Caprioli; T Manuelian; H H Neumann; M Noris; G Remuzzi
Journal:  Int Immunopharmacol       Date:  2001-03       Impact factor: 4.932

9.  Identification of the second heparin-binding domain in human complement factor H.

Authors:  T K Blackmore; J Hellwage; T A Sadlon; N Higgs; P F Zipfel; H M Ward; D L Gordon
Journal:  J Immunol       Date:  1998-04-01       Impact factor: 5.422

Review 10.  The genetics and pathogenesis of haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura.

Authors:  Anna Richards; Judith A Goodship; Timothy H J Goodship
Journal:  Curr Opin Nephrol Hypertens       Date:  2002-07       Impact factor: 2.894

View more
  13 in total

1.  Identification of complement regulatory domains in vaccinia virus complement control protein.

Authors:  Jayati Mullick; John Bernet; Yogesh Panse; Sharanabasava Hallihosur; Akhilesh K Singh; Arvind Sahu
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

2.  Immunophysical properties and prediction of activities for vaccinia virus complement control protein and smallpox inhibitor of complement enzymes using molecular dynamics and electrostatics.

Authors:  Li Zhang; Dimitrios Morikis
Journal:  Biophys J       Date:  2006-02-10       Impact factor: 4.033

3.  Enhancing complement control on endothelial barrier reduces renal post-ischemia dysfunction.

Authors:  Sathnur B Pushpakumar; Gustavo Perez-Abadia; Chirag Soni; Rong Wan; Nathan Todnem; Phani K Patibandla; Tathyana Fensterer; Qunwei Zhang; John H Barker; Claudio Maldonado
Journal:  J Surg Res       Date:  2011-07-07       Impact factor: 2.192

4.  Fraud rocks protein community.

Authors:  Brendan Borrell
Journal:  Nature       Date:  2009-12-24       Impact factor: 49.962

5.  Smallpox inhibitor of complement enzymes (SPICE): dissecting functional sites and abrogating activity.

Authors:  M Kathryn Liszewski; Marilyn K Leung; Richard Hauhart; Celia J Fang; Paula Bertram; John P Atkinson
Journal:  J Immunol       Date:  2009-08-10       Impact factor: 5.422

Review 6.  Poxvirus proteomics and virus-host protein interactions.

Authors:  Kim Van Vliet; Mohamed R Mohamed; Leiliang Zhang; Nancy Yaneth Villa; Steven J Werden; Jia Liu; Grant McFadden
Journal:  Microbiol Mol Biol Rev       Date:  2009-12       Impact factor: 11.056

7.  Influence of glycosylation and oligomerization of vaccinia virus complement control protein on level and pattern of functional activity and immunogenicity.

Authors:  Girish J Kotwal
Journal:  Protein Cell       Date:  2011-01-08       Impact factor: 14.870

8.  Structure of complement factor H carboxyl-terminus reveals molecular basis of atypical haemolytic uremic syndrome.

Authors:  T Sakari Jokiranta; Veli-Pekka Jaakola; Markus J Lehtinen; Maria Pärepalo; Seppo Meri; Adrian Goldman
Journal:  EMBO J       Date:  2006-04-06       Impact factor: 11.598

9.  Heparan Sulfate Regulates the Structure and Function of Osteoprotegerin in Osteoclastogenesis.

Authors:  Miaomiao Li; Shuying Yang; Ding Xu
Journal:  J Biol Chem       Date:  2016-10-03       Impact factor: 5.157

10.  Smallpox inhibitor of complement enzymes (SPICE): regulation of complement activation on cells and mechanism of its cellular attachment.

Authors:  M Kathryn Liszewski; Paula Bertram; Marilyn K Leung; Richard Hauhart; Lijuan Zhang; John P Atkinson
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.